Skip to main content

Month: March 2020

Issue of Supplementary Prospectus

Octopus Apollo VCT plc13 March 2020Issue of Supplementary ProspectusThe Board of Octopus Apollo VCT plc (the “Company”) announces that a Supplementary Prospectus (the “Supplementary Prospectus”) relating to the Company’s Offer for Subscription to raise up to £30 million (the “Offer”), in the 2019/2020 and 2020/2021 tax years has been published today.The Supplementary Prospectus refers to the increase, due to investor demand, in the size of the Offer from £30 million to £50 million.A copy of the Supplementary Prospectus has been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at:http://www.morningstar.co.uk/uk/NSM    Copies of the Supplementary Prospectus will also be available from the Company’s website:http://www.octopusinvestments.comFor...

Continue reading

Crawford United Corporation Announces Fourth Quarter 2019 Results

CLEVELAND, March 13, 2020 (GLOBE NEWSWIRE) — Crawford United Corporation (OTC: CRAWA), a growth-oriented holding company serving diverse markets, today reported results for the three-month and twelve-month periods ended December 31, 2019.For the quarter ended December 31, 2019, sales were $21.1 million compared with $21.1 million in the same period last year. In this quarter, the Company recorded operating income of $2.6 million compared with operating income of $2.4 million in the same period last year, an increase of 8%. Net income was $1.7 million, or $0.51 per fully diluted share, compared to $1.3 million, or $0.43 per fully diluted share in the prior year.For the twelve months ended December 31, 2019, sales were $89.7 million compared with $66.4 million in the same period last year, an increase of 35%. In this twelve-month period,...

Continue reading

Advaxis Reports First Quarter Ended January 31, 2020 Financial Results and Provides a Pipeline Update

PRINCETON, N.J., March 13, 2020 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced an update on its clinical pipeline and financial results for the first quarter ended January 31, 2020.Key recent corporate and clinical pipeline updates:Presented updated clinical data from the ongoing Phase 1/2 ADXS-503 trial at the I/O 360° Conference. Data presented showed that the first two patients treated in the combination arm, who previously progressed on KEYTRUDA®, achieved a partial response with substantial tumor shrinkage of nearly 60% and the other patient achieving stable disease with a 25% reduction in a target lesion.Presented updated survival data from the Phase 1/2 ADXS-PSA trial at the ASCO Genitourinary...

Continue reading

Cartoning Machines Market to Reach USD 2.83 billion by 2026, Rapid Growth of Consumer Goods Industry to Promote Growth says Fortune Business Insights™

Pune, March 13, 2020 (GLOBE NEWSWIRE) — The global cartoning machines market size is anticipated to reach USD 2.83 billion by 2026, on account of the increasing demand for flexible and compact cartoning machines. Cartoning machines are packaging tools used for packaging of confectionery, medicine, bottled food products, sundry goods, cosmetics, and other products. A recently published report titled, “Cartoning Machines Market Size, Share & Industry Analysis, By Type (Vertical/Top-Load Cartoning Machine, Horizontal/End-Load Cartoning Machine), By End-Use Industry (Food & Beverage, Healthcare & Pharmaceuticals, Consumer Goods, Others) and Regional Forecasts, 2019-2026,” by Fortune Business insights™ provides a comprehensive overview on the market and its prime growth trajectories. According to this report, the market...

Continue reading

Tauriga Sciences, Inc. Sets New Daily Company Record for Number of E-Commerce Orders Generated

The Company Recorded 43 Individual E-Commerce Orders on Thursday, March 12, 2020NEW YORK, NY, March 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has set a new daily record for the number of E-Commerce orders generated – on its Company E-Commerce website (www.taurigum.com). The Company continues to experience strength in its E-Commerce business: a trend that has continued over the past few months.The Company’s E-Commerce Website:  www.taurigum.comThe Company’s E-Commerce Store:  https://www.taurigum.com/storeIn other news, the...

Continue reading

ORBIT INTERNATIONAL CORP. REPORTS 2019 YEAR END RESULTS

2019 Net Income of $463,000 ($0.13 per diluted share) v. $2,225,000 ($0.62 per diluted share) in Prior YearFourth Qtr. 2019 Net Loss of $216,000 ($0.06 loss per diluted share) v. Net Income of $472,000 ($0.13 per diluted share) in Prior Yr. PeriodCurrent Full Year Earnings Include $131,000 ($0.04 per diluted share) in Acquisition Costs Related to Q-Vio AcquisitionPrior Full Year Earnings Include $573,000 ($0.16 per diluted share) Deferred Tax BenefitBacklog at 12/31/19 at $20,834,000Company Repurchased 45,949 of its Common Shares at an Average Price of $5.74 Per Share Since Beginning of Q4 2019HAUPPAUGE, N.Y., March 13, 2020 (GLOBE NEWSWIRE) — Orbit International Corp. (OTC PINK:ORBT) today announced results for the fourth quarter and year ended December 31, 2019.Fourth Quarter 2019 vs. Fourth Quarter 2018Net sales were $6,480,000,...

Continue reading

Form 8.3 – Countrywide plc

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

NEW YORK, March 13, 2020 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced financial results for the fourth quarter and full-year 2019.“The recent positive top line results from the Phase 3 CONDOR trial of PyL™ highlights the potential of our radiopharmaceutical pipeline. By merging with Lantheus, we believe we can leverage Lantheus’ long-standing expertise in complex manufacturing, supply chain and commercial excellence to deliver on the promise of PyL, AZEDRA® and our complementary PSMA-targeted product portfolio,” said David Mims, Interim Chief Executive Officer of Progenics.Mr. Mims continued, “The reconstituted Progenics Board’s support for the Lantheus merger is based on the culmination of our thorough evaluation of the business prospects and operations of Progenics as a stand-alone business,...

Continue reading

How coronavirus affects stock trading

As the coronavirus continues to spread, many companies are suffering huge losses.At the same time, stocks of certain corporations, in turn skyrocketed in value. Business is now actively considering ways to capitalize on the coronavirus. This threatens to increase prices for many products. Our website understood who earned money on the Asian epidemic and how it would turn out for buyers. Chinese coronavirus has become the most discussed topic in recent months. The extent of its spread, the number of deaths and infected people really calls a panic sentiments in society. As you know, people are ready to pay any amount of money in the struggle for survival, so demand creates supply and radically changes the price of requested goods.In real life now pharmaceutical companies are still won, with sales of antiviral medicines increasing several...

Continue reading

Reliance Trading Co. Limited – Current News on Stock Market Today

It seems like the U.S. market is not getting any better this coming week as just this Sunday evening, oil futures tumbled down by 30% which made DJIA futures sink by 900 points. Not to mention that the yield on the 10-year U.S. Treasury bond plunged as low as 0.5% making another record blow to the stock market history. The reason why the oil market is down by 30% is because the crude producing country has declined the production cutbacks that created a kicked off a price war and sent Brent futures drop to a $32 per barrel, which by the way they started this year with almost $65 per barrel. With the news, Oil giant Saudi Aramco plummets below its IPO price for the first time in the history. Still affected by the fear and anxiety the growing number of coronavirus cases all around the world, the global market and the economic growth is now...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.